0001493152-24-046765.txt : 20241119 0001493152-24-046765.hdr.sgml : 20241119 20241119143727 ACCESSION NUMBER: 0001493152-24-046765 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241108 FILED AS OF DATE: 20241119 DATE AS OF CHANGE: 20241119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BELL LON E CENTRAL INDEX KEY: 0000941593 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42204 FILM NUMBER: 241475400 MAIL ADDRESS: STREET 1: C/O AMERIGON INC STREET 2: 5462 IRWINDALE AVENUE CITY: IRWINDALE STATE: CA ZIP: 91706 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Invizyne Technologies Inc CENTRAL INDEX KEY: 0002010788 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 834550057 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 750 ROYAL OAKS DR CITY: MONROVIA STATE: CA ZIP: 91016 BUSINESS PHONE: (626) - 415 - 1488 MAIL ADDRESS: STREET 1: 750 ROYAL OAKS DR CITY: MONROVIA STATE: CA ZIP: 91016 3 1 ownership.xml X0206 3 2024-11-08 0 0002010788 Invizyne Technologies Inc IZTC 0000941593 BELL LON E C/O 750 ROYAL OAKS DRIVE, SUITE 106 MONROVIA, CA 91016 1 0 0 0 Stock Options for Common Stock 8.00 2025-07-01 2031-03-31 Common Stock 51939 D The options vest as follows: The first 10,392 shares vest on July 1, 2025, and the balance vest at the rate of 2,598 shares per quarter, commencing on October 1, 2024 and become exercisable once vested. All shares are vested by 03/31/2029 /s/ Lon Edward Bell 2024-11-18